ConductScience.org, home

Paper33748017

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).

Liang L and 9 others. J Hepatocell Carcinoma, 2021. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml). Papers, record 33748017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33748017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).
PubMed
Journal
J Hepatocell Carcinoma
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.31
iCite
Revised in PubMed
2022-04-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liang LLei
2Wang MDMing-Da
3Zhang YMYao-Ming
4Zhang WGWan-Guang
5Zhang CWCheng-Wu
6Lau WYWan Yee
7Shen FFeng
8Pawlik TMTimothy M
9Huang DSDong-Sheng
10Yang TTianhttps://orcid.org/0000-0003-0575-0698

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128032546Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy.J Surg Res2017https://conductscience.org/library/papers/28032546PubMed
230970190Hepatocellular Carcinoma.N Engl J Med2019https://conductscience.org/library/papers/30970190PubMed
330017783Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma.HPB (Oxford)2019https://conductscience.org/library/papers/30017783PubMed
423816006Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.Am Surg2013https://conductscience.org/library/papers/23816006PubMed
531285588Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.Br J Cancer2019https://conductscience.org/library/papers/31285588PubMed
623754648Partial hepatectomy for ruptured hepatocellular carcinoma.Br J Surg2013https://conductscience.org/library/papers/23754648PubMed
729571804Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.Eur J Radiol2018https://conductscience.org/library/papers/29571804PubMed
831954491Advances in resection and transplantation for hepatocellular carcinoma.J Hepatol2020https://conductscience.org/library/papers/31954491PubMed
926813914A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma.Ann Surg2016https://conductscience.org/library/papers/26813914PubMed
1030665869Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol2019https://conductscience.org/library/papers/30665869PubMed
1129376136Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.Hepatoma Res2018https://conductscience.org/library/papers/29376136PubMed
1230548884Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.Hepatology2019https://conductscience.org/library/papers/30548884PubMed
1332472951Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.Oncologist2020https://conductscience.org/library/papers/32472951PubMed
1429805966Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.Can J Gastroenterol Hepatol2018https://conductscience.org/library/papers/29805966PubMed
1524123097On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.Hepatology2014https://conductscience.org/library/papers/24123097PubMed
1612547409Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.J Hepatol2003https://conductscience.org/library/papers/12547409PubMed
1722535689Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.Hepatology2012https://conductscience.org/library/papers/22535689PubMed
1823548745Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.Dig Surg2012https://conductscience.org/library/papers/23548745PubMed
1931829979Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.Aging (Albany NY)2019https://conductscience.org/library/papers/31829979PubMed
2029624699Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.Hepatology2018https://conductscience.org/library/papers/29624699PubMed

See all 56 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42068148Association Between Multi-Laboratory Parameters Pre- and Post-Treatment and Pathological Features and Their Values in Clinical Decision in Primary Hepatic Carcinoma.J Clin Lab Anal2026https://conductscience.org/library/papers/42068148PubMed
41971433Multiphasic CT-based multimodal deep learning model for predicting early hepatocellular carcinoma recurrence following liver transplantation.Front Oncol2026https://conductscience.org/library/papers/41971433PubMed
40636774Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study.J Hepatocell Carcinoma2025https://conductscience.org/library/papers/40636774PubMed
39917418Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients.J Clin Exp Hepatol2025https://conductscience.org/library/papers/39917418PubMed
39555448The impact of tumor burden score on prognosis in patients after radical resection of hepatocellular carcinoma: a single-center retrospective study.Front Oncol2024https://conductscience.org/library/papers/39555448PubMed
38907676Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients.Oncologist2024https://conductscience.org/library/papers/38907676PubMed
38903723
Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (γ)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational study.
Front Oncol2024https://conductscience.org/library/papers/38903723PubMed
37925654
Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Ann Surg Oncol2024https://conductscience.org/library/papers/37925654PubMed
37746650Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma.World J Gastrointest Oncol2023https://conductscience.org/library/papers/37746650PubMed
36755690Whole-Transcriptome Sequencing Combined with High-Dimensional Proteomic Technologies Reveals the Potential Value of miR-135b-5p as a Biomarker for Hepatocellular Carcinoma.Biomed Res Int2023https://conductscience.org/library/papers/36755690PubMed
36686731Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China.Front Oncol2022https://conductscience.org/library/papers/36686731PubMed
36207940[The consensus on tertiary prevention of primary liver cancer (2022 version)].Zhonghua Gan Zang Bing Za Zhi2022https://conductscience.org/library/papers/36207940PubMed
35986784Short- and long-term outcomes of laparoscopic versus open liver resection for large hepatocellular carcinoma: a propensity score study.Surg Today2023https://conductscience.org/library/papers/35986784PubMed
35273701Orthotopic liver transplantation improves postoperative quality of life, survival rate and reduces recurrence rate in patients with liver cancer.Am J Transl Res2022https://conductscience.org/library/papers/35273701PubMed
35178834E2F1-mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10.Cancer Sci2022https://conductscience.org/library/papers/35178834PubMed
35127471Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.Front Oncol2021https://conductscience.org/library/papers/35127471PubMed
34408472
The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.
Int J Gen Med2021https://conductscience.org/library/papers/34408472PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33748017

GET https://conductscience.org/api/papers/v1/33748017/references?page=2